Background: Information related to histamine-induced cellular responses in C6 glioma cells through second messenger pathways has not been fully studied, especially the involvement of arachidonic acid (AA) metabolism. In addition, specific labeled ligand binding to histamine receptor sites still needs to be clarified. Methods: Labeled mepyramine ligand was used to study its binding sites; [ ]i, and they are coupled to phospholipase A2 (PLA2) to generate GPI and AA with its metabolite release. The transient increase in [Ca 2þ ]i can be attributed to Ca 2þ release from intracellular stores, whereas the sustained increase in [Ca 2þ ]i is due to influx of extracellular calcium ions. The sustained increase in [Ca 2þ ]i plays a role in the activation of histamine receptorcoupled PLA2.
Introduction
The C6 glioma cell line was established around 1968, 1 and it has been used for physiologic and pharmacologic studies because this cell line, having a glial cell origin, contains many types of receptors such as adrenergic, serotonergic, muscarinic, adenosine 5 0 -triphosphate (ATP), bradykinin, and endothelin. For the histaminergic system, Peakman and Hill 5 reported that histamine caused an increase in [ 3 H] phosphatidylinositol (PI) turnover and inositol 4-phosphate (IP 1 ) accumulation; however, an apparent lack of endogenous histamine H 1 receptors in C6 cells was reported by Liu and others 6 and Fujimoto and colleagues. 7 Therefore, it was interesting to know if histaminemediated signal transduction system can still be detected in this cell line or not.
Previous studies have shown that histamine H 1 receptor stimulation resulted in a pronounced release of arachidonic acid (AA) in smooth muscle cells of the DDT1 MF2 cell line. 8 In addition, reports showed that dysregulation of AA metabolism plays an important role in influencing critical aspects of tumorigenesis. 9 Furthermore, some evidence suggested a crucial role of prostaglandin E2, a metabolic product of AA, in the control of growth, survival, and angiogenic potential of tumor cells. 10 We then decided to use C6 glioma cancer cells to see if there is a link between AA metabolism and histamine interacting with its receptor site.
Little information was found about histamine-treated cells possibly having an alternative pathway of AA metabolism, which is closely linked to its inflammatory role, so it is worth conducting more studies on this issue. At the beginning of this study, we observed a more than 11-fold increase on IP 1 accumulation with the use of [ 3 H] labeled inositol under the maximal stimulation of histamine (at 100 mM), which could be blocked by histamine H 1 receptor antagonist chlorpheniramine. This is evidence of the presence of histamine H 1 receptor expressed endogenously in these glioma cells. 5 In addition, from the result of the [ 3 H] mepyramine binding to H 1 receptor in cell membranes isolated from C6 glioma cells, the data revealed a significant specific binding.
The presence of histamine H 1 receptors on glial cells was firstly indicated by studies of the binding of [ 3 H] histamine and [
3 H] mepyramine to glial cells in explant cultures from rat brain. 11 [ 3 H] mepyramine binding studies had since revealed the presence of H 1 receptors on rat astrocytes in vitro, 12 and activation of these receptors had been shown to stimulate phosphoinositide hydrolysis. 13 Since histamine plays an important physiologic role in central 14 and peripheral systems, 15 and is involved in inflammatory or allergic syndromes of many reactions, there is a need for more detailed studies of its second messengers in the cells. We used C6 glioma cells to study the involvement of these candidates, including calcium movement, AA metabolism, and other phospholipid metabolism in the signal transduction system. If this cell line is a good model for such an investigation, further studies on down-regulation, desensitization by histamine or other mediators can be performed, including studies that examine the drug effect on the histaminergic receptor system.
Methods

Materials
The radioisotopes used in this study, [ 
Cell culture
The C6 glioma cell line was a gift from Professor TehCheng Chou at the Institute of Neuroscience at the National Yang-Ming University (Taipei, Taiwan). These cells were cultured in Ham's F-10 medium (JRH Biosciences, Inc., Lenexa, KS, USA) with 10% fetal bovine serum (Hyclone Co., Logan, UT, USA). Cells in T-75 flasks (BD Biosciences, Franklin Lakes, NJ, USA) were kept at 37 C, 5% CO 2 and 95% O 2 incubator. The culture medium was changed every other day. This cell line has been used widely for decades since its establishment in 1968. 1 
Methods for cell growth in experiments
C6 glioma cells were seeded on three glass cover slips (10 Â 40 mm) and kept in a 60-mm culture flask, and then the flask was kept in an incubator until cell growth reached a confluent state. Before the experiment, the medium was changed to F-10 culture medium without addition of 10% fetal bovine serum. Labeled materials were added to each flask for a period of time, and then washed out unlabeled portion with washing buffer [containing NaCl (116 mM), NaHCO3 (26.2 mM), NaH2PO4 (1 mM), KCl (2.5 mM), MgSO4 (1.5 mM), CaCl2 (2.5 mM), and glucose (20 mM)] three times.
2.4. PI turnover study 5, 16 Labeled [
3 H] myo-inositol (1 mCi/ml) was added into each flask for a 24-hour incubation in a F10 culture medium without 10% fetal bovine serum. At the end of incubation, this culture medium was removed and a washing buffer was used to wash these cells three times. A 2.475 ml of buffer solution was added into incubation flask and maintained/kept at 37 C for 40 minutes. Then, 10 mM LiCl was added to prevent the breakdown of inositol phosphated into inositol. After that, a stimulator such as histamine was added into the flask for 60 minutes. At the end of incubation, an ice cold washing buffer was used to wash twice to end the reaction in the flask. The glass plates were removed for counting and kept in a scintillation counting vial. For further extraction of inositol phosphates, the method of Pearce and colleagues 17 was used.
Analysis of GPI and PI 5
The PI products were analyzed with anion-exchange chromatography. 0.5 ml of AGI Â 8 resin (100e200 mesh, formate form) was kept in a Pasteur pipette to form a column. Diluted aqueous extraction material was added (6.4 ml) into the column, and the PI was combined with resin. Then, 10 ml of double-distilled water was added to wash out the free form of PI. Then, 6 ml of 60 mM sodium formate/5 ml sodium tetraborate was added to wash the 3 H] AA (0.15 mCi/ml) of F-10 cultured medium (not containing bovine serum albumin) and kept at 37 C incubator for 24 hours to label the cells with radioisotope material. Before the reaction was started, the radioisotope material was removed and washed five times with washing buffer containing NaCl (118 mM); KCl (4.7 mM); glucose (10 mM); [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer (20 mM) pH7.4 at 37 C. Following this, 2.475 ml buffer solution (composition shown before) plus 25 ml of test sample at the selected concentration was added to start the reaction at 37 C. At the end of reaction time, 1 ml of cell culture medium was removed, placed in a centrifuge tube and centrifuged at 200 Â g for 10 minutes to precipitate the cells. After centrifugation, 1 ml of supernatant was removed and 3 ml of scintillation counter fluid was added and mixed prior to counting with scintillation counter.
Intracellular calcium determination 19
C6 glioma cells in 10 ml of loading buffer (containing 150 mM NaCl, 5 mM KCl, 2.2 mM CaCl2, 1 mM MgCl2, 5 mM glucose, and 10 mM HEPES buffer at pH7.4) were kept in centrifuge tubes and centrifuged at 750 Â g for 3 minutes, and the pellet was washed twice with washing buffer. The cells (1 Â 10 7 cells/ml) were removed and 5 mM fura-2/AM was added and then kept at 37 C for 45 minutes before centrifugation. The supernatant was then removed, and cells were washed with loading buffer twice to remove the remaining fura-2/AM. The remaining cells were suspended with loading buffer at a concentration of 5 Â 10 6 cells/ml and kept in a 15-ml plastic centrifuge tube. It was covered with aluminum foil to prevent light penetration. The tube was in a dark condition during the assay period. At the end of experiment, 0.3% digitonin was added to make fura-2 combined with Ca 2þ to obtain R max , and ethylene diamine tetraacetic acid (EGTA) was added to a final concentration of 0.1 M to complete with fura-2 for Ca 2þ to obtain R min . Intracellular calcium concentration was obtained by using the method of Grynkiewicz and colleagues. 16 
[
3 H] mepyramine binding assay 12 Cell membranes (about 150 mg of membrane protein in 0.4 ml) prepared from C6 glioma cells, using the method of Smit and colleagues, 21 were incubated with 12 nM [ 3 H] mepyramine at 25 C for 60 minutes: one set with the presence of 1 mM chlorpheniramine as a nonspecific binding and in another set without the presence of chlorpheniramine as a total binding. At the end of incubation, 5 ml of cold washing buffer was added to each tube to stop the reaction. Then the whole volume of the reaction mixture was poured through the GG/B filter paper (the filter papers were soaked with 1 mM mepyramine solution prior to use) under the vacuum pump and then washed twice with 4 ml washing buffer. The filter papers kept in counting vials were dried for 1 hour at 30 C before adding 3 ml of Ready Safe scintillation counter fluid (Beckman Co., Fullerton, CA, USA). Then, these vials were vortexed vigorously for 3e5 minutes, and then we let them stand for 30 minutes stately before being put in a beta counter for counting.
Data analysis
In this study, a two-sample t test was used for statistical analysis; the significant difference was set as p < 0.05 between the two groups in the comparison. Each experiment was carried out in triplicate, and each test was repeated at minimum three times.
Results
Binding of [
3 H] mepyramine to H1 receptor in membrane preparation of C6 glioma cells Cell membranes isolated from C6 glioma cells were incubated with or without 100 mM chlorpheniramine in the presence of 12 nM [ 3 H] mepyramine for binding assay. A 77% specific binding (against 23% nonspecific binding) of labeled ligand to H 1 receptor sites (i.e., the percentage of [(3250 dpm/ tube of total binding minus 773 dpm/tube of nonspecific binding)/3250 dpm/tube of total binding, n ¼ 4] under this condition was observed (Table 1) .
Histamine-induced IP 1 accumulation in C6 glioma cells
At 37 C and in the presence of 10 mM LiCl, histamine at 100 mM caused [ 3 H] IP 1 accumulation, and this response was a time-dependent phenomenon. The maximal response of histamine at this concentration was found at 60 minutes and maintained at plateau level for about 10 minutes, and then the response went down (Fig. 1A) . From the concentration response study, histamine at 100 mM caused a maximal response of 11.8-fold increase of IP 1 accumulation with respect to the basal level (Fig. 1B) . Based on the experimental data, the EC50 (effective concentration in 50% response) was calculated as 4.1 mM.
Histamine-induced GPI accumulation in C6 glioma cells
At 37 C and in the presence of 10 mM LiCl, histamine at 100 mM caused [
3 H]GPI accumulation in a time dependentmanner. The maximal response was found at 60 minutes and stayed at this plateau level up to 80 minutes ( Fig. 2A) . Also, this accumulation response of GPI in the presence of histamine was a concentration-dependent phenomenon. Based on the data obtained, there was a 2.2-fold increase at maximal response with respect to basal level, and the EC50 value was calculated as 2.8 mM (Fig. 2B) .
Histamine-induced AA and its metabolite accumulation in C6 glioma cells
At 37 C and in the presence of 100 mM of histamine, there was a time-dependent increase of AA and its metabolite accumulation (Fig. 3A) . Histamine-induced maximal response of AA accumulation at 60 minutes. This was a 1.6-fold increase over the basal level (Fig. 3B) . The EC50 value was calculated as 2.8 mM. ]i. The increase was observed in two phases. The first phase of increase was transient and happened within 1e2 seconds, and the second phase of increase was sustained, lasting from 2 seconds to more than 1 minute. For transient phase, a maximal response was seen at 100 mM of histamine (in-site free calcium concentration of the cells was 730 AE 80 nM). The EC50 was 4.9 mM. For the sustained phase, the maximal calcium increase was observed at 3.3 mM of histamine. The calculated EC50 was 0.63 mM. The maximal responses lasted more than 30 minutes (data not shown). If 100 mM of histamine antagonist chlorpheniramine was added, the sustained level of calcium concentration was found decreased to basal level (Fig. 4A) . In addition, all the histamine-induced biologic response observed in this study could be completely blocked by chlorpheniramine (Fig. 4B and Table 2 ). In the presence of 2 mM of EGTA, the transient phase of intracellular calcium increase was inhibited by 20% only, whereas sustained phase of intracellular calcium increase was inhibited by 95% (Fig. 5A) . Under these conditions, GPI accumulation was inhibited by 80% (Table 3) . It is clear that 80% or more of the transient phase of calcium increases observed in the transient phase were from cellular storage sites, whereas intracellular calcium increases seen in the sustained phase were derived mainly from extracellular sources. The influx of calcium into the cells caused the activation of 
Effect of calcium channel blocker La 3þ on histamineinduced intracellular calcium response
The addition of 1 mM La 3þ completely blocked a histamine-induced sustained calcium increase (Fig. 5B) . This is evidence that the sustained phase of intracellular free calcium ion increase is a result of calcium influx from extracellular sources.
Effect of receptor-mediated calcium channel blocker (RMCE) on histamine-induced calcium response
In the presence of 10 mM SKF 96365, a receptor-mediated calcium entry inhibitor, 22 histamine-induced transient phase of calcium increase was inhibited by about 20%, whereas sustained calcium increases were inhibited by 67% (Fig. 6A) . However, L-type calcium channel blockers such as nifedipine or verapamil did not block sustained calcium phase. Higher KCl concentrations did not cause intracellular calcium increase (data not shown). This observation demonstrated that histamineinduced sustained calcium increase was not due to the opening of the voltage-dependent calcium channel, but rather the opening of receptor-mediated calcium channels.
Effects of intracellular calcium antagonist TMB-8 on histamine-induced calcium response
Under the presence of 100 mM of TMB-8, an intracellular calcium antagonist and a calcium influx blocker, histamineinduced transient-phase calcium increases were inhibited by 83%, and histamine-induced sustained-phase calcium increases were inhibited by 80% (Fig. 6B) . 
Discussion
From the [
3 H] mepyramine binding data, the C6 glioma cell contains endogenous H 1 receptors. Under 12 nM of labeled mepyramine (a concentration close to the Kd (dissociation ). Histamine-induced transient [Ca 2þ ]i increase, with an EC50 of 4.9 mM, was higher than its sustained [Ca 2þ ]i increase, with EC50 of 0.63 mM. The sensitivity of histamine-induced sustained calcium phase increase is different from that of transient calcium phase increase. Similar phenomenon has been found in human neuroblastoma cells 27 and parotid acinar cells. 28 In the presence of 2 mM EGTA, a 20% inhibition of histamine-induced transient [Ca 2þ ]i increase was observed, whereas a 95% inhibition of histamine-induced sustained [Ca 2þ ]i increase was found when compared with the data of the medium without EGTA. These results revealed that about 80% of histamine-induced transient Ca 2þ increase is from intracellular storage sites, and its sustained phase calcium ion increase is from extracellular calcium ion influx, since this effect could be blocked in the presence of 1 mM La 3þ . In the presence of 10 mM of SK&F 96365, 9 histamine-induced transient calcium ion increase could be reduced by 20%, whereas sustained calcium ion increase was reduced by 70%. In the presence of 100 uM 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester (TMB-8), both transient calcium and sustained phase of calcium level increases were reduced by 83 and 80%, respectively. This is consistent with reports that TMB-8 is a calcium influx blocker and an intracellular calcium antagonist. 29 In this study, higher extracellular potassium levels were unable to cause an increase in intracellular calcium. In addition, L-type voltage dependent calcium channel blockers nifedipine and verapamil were unable to reduce sustained calcium ion increase by histamine (data not shown). This is evidence that sustained calcium increase induced by histamine was from H 1 receptor-mediated calcium channels, rather than from voltage-dependent calcium channels.
Histamine-induced GPI accumulation and AA with its metabolite release had an EC50 value of 2.8 mM. It is an indication that both GPI and AA, with its metabolite accumulation, are mediated by the PI hydrolysis pathway via a receptor-coupled G protein system (likely a pertussis toxinsensitive G protein) to activate PLA2. However, histamineinduced IP 1 accumulation, and its EC50 value was 4.2 mM (versus 2.8 mM obtained in GPI accumulation), indicates that it may couple to a different G-protein (likely a pertussis toxininsensitive G protein) to activate phosphatidylinositolphospholipase C (PI-PLC). In the literature, histamine H 1 receptor activation was found by Murayama and colleagues 30 to be mediated via a pertussis toxin-sensitive G-protein and subsequently activate PLA2 in rabbit platelets. Furthermore, Brooks and coworkers 31 proposed that the activation of PLA2 is coupled to influx of external calcium but not to mobilization of intracellular calcium in C62B glioma cells. Here, influx of external calcium caused by histamine is likely through activation of Gq/11 protein in PI-PLC pathway.
From the clinical point of view, our data results revealed that the chemical mediator of histamine can interact with its receptors in glioma cells and increase the AA metabolisms and the prostaglandin levels in these cells. Hence, it is well documented that abnormal metabolisms of arachidonic acid and its metabolites are intimately linked to cancer biology. 32 Further studies on this aspect are needed.
In conclusion, in C6 glioma cells, histamine interacted with histamine H 1 receptors and caused the activation of PI-PLC, resulting in IP 1 accumulation and intracellular calcium ion increase. Also, it activated PLA2 and resulted in GPI accumulation and AA release. Many physiologic events can happen after the increase of [Ca 2þ ]i, inositol phosphates and AA with metabolite release. Since this cell line uses many secondary messengers of histamine to express the cell responses, it is worthwhile to further study receptor desensitization and/or down-regulation after prolonged activation of H1 receptors. In addition, studies on which chemicals that can activate or inhibit this signal transduction pathway, and they may become some useful therapeutic agents.
